title: Does treatment with olmesartan improve arterial stenoses due to fibromuscular dysplasia?
authors.forename: Alberto
authors.initials: A
authors.lastname: Mazza
authors.forename: Stefano
authors.initials: S
authors.lastname: Cuppini
authors.forename: Sergio
authors.initials: S
authors.lastname: Zamboni
authors.forename: Laura
authors.initials: L
authors.lastname: Schiavon
authors.forename: Luca
authors.initials: L
authors.lastname: Zattoni
authors.forename: Andrea
authors.initials: A
authors.lastname: Viale
authors.forename: Francesco
authors.initials: F
authors.lastname: Corbetti
authors.forename: Roberta
authors.initials: R
authors.lastname: Ravenni
authors.forename: Alberto
authors.initials: A
authors.lastname: Sacco
authors.forename: Edoardo
authors.initials: E
authors.lastname: Casiglia
mesh_terms: D047228:Angiotensin II Type 1 Receptor Blockers / Q000627:therapeutic use*; D015415:Biomarkers; D016893:Carotid Stenosis / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000209:etiology*; D005260:Female; D005352:Fibromuscular Dysplasia / Q000150:complications* / Q000000981:diagnostic imaging; D006801:Humans; D007091:Image Processing, Computer-Assisted; D007093:Imidazoles / Q000627:therapeutic use*; D007249:Inflammation / Q000378:metabolism; D008875:Middle Aged; D017382:Reactive Oxygen Species / Q000378:metabolism; D013777:Tetrazoles / Q000627:therapeutic use*; D014057:Tomography, X-Ray Computed; D014463:Ultrasonography
chemical_list: D047228:Angiotensin II Type 1 Receptor Blockers; D015415:Biomarkers; D007093:Imidazoles; D017382:Reactive Oxygen Species; D013777:Tetrazoles; C437965:olmesartan